Delivery Order SPE2DE22D0008-SPE2D625F0ZPK
Award Date 8/14/25
Potential Completion Date 8/19/25
Potential Value $2.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Chicago, IL 60607, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain division, awarded a delivery order contract to Alba Bioscience, Inc. for ALBACLONE anti-FYB antibody screening products. The contract, valued at $12,875 with a firm fixed price structure, was executed on September 4, 2025, with an ultimate completion date of September 9, 2025. This non-set-aside award represents a continuation of Alba Bioscience's established role as a critical supplier of specialized in vitro diagnostic...
- Alba Bioscience, Inc. was awarded a delivery order contract on July 15, 2025, for ALBACLONE Anti-K antibodies with a firm fixed price ceiling value of $3,400. The contract is funded by the Defense Logistics Agency's Medical Supply Chain division and will be performed in Chicago, Illinois, with an ultimate completion date of July 18, 2025. This non-set-aside award recognizes Alba Bioscience's established position as a critical supplier of in vitro diagnostic reagents and blood bank products to...
- Alba Bioscience, Inc. was awarded a delivery order contract by the Defense Logistics Agency's Medical Supply Chain division on August 14, 2025, for the supply of ALBACLONE Anti-D Blend, a specialized blood bank reagent used in immunohematology testing. This firm fixed-price contract carries a ceiling value of $1,464.00 with an ultimate completion date of August 19, 2025. The contract was awarded on a non-competitive basis with no set-aside designation, reflecting Alba Bioscience's established...
- The Defense Logistics Agency, operating under the Defense or Civilian designation, awarded a delivery order contract (4568409675) to Alba Bioscience, Inc. on June 2, 2025, for the supply of ALBACLONE Anti-K antibodies. The contract represents a firm fixed price delivery order with a ceiling value of $15,944.00 and an ultimate completion date of June 5, 2025. The award was made on a non-set-aside basis, reflecting Alba Bioscience's competitive standing as an established supplier of specialized...
- Alba Bioscience, Inc. received a $2,030 firm fixed-price delivery order from the Department of Defense's Medical Supply Chain on June 5, 2025, for the ALBACYTE Antibody ID Panel (16-Cell). The contract, which carries an ultimate completion date of August 11, 2025, was awarded without a set-aside designation, reflecting Alba Bioscience's competitive standing as a supplier of specialized in vitro diagnostic products. Performance will take place in Chicago, Illinois, where the vendor maintains...
- Alba Bioscience, Inc., a Chicago-based supplier of in vitro diagnostics and blood bank reagents, was awarded a delivery order for ALBACYTE Antibody ID Panel (10-Cell) on June 2, 2025, with a ceiling value of $12,895. The contract is a firm fixed price delivery order with an ultimate completion date of August 6, 2025, and was issued without a set-aside designation, indicating competitive procurement. The award was funded by the Defense Logistics Agency's Medical Supply Chain division,...
- This federal contract award, with ID SPE2DE22D0008|SPE2D625F1414, was issued by the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in in vitro diagnostics, blood bank reagents, and quality control materials. The contract, with a ceiling value of $1,118.00, is for the delivery of "ALBACLONE ANTI-A" products, which are likely blood typing reagents or antibodies used in blood banking operations. The contract is a Delivery...
- The Defense Health Agency awarded a $45,227.88 firm fixed-price purchase order to Alba Bioscience, Inc. for Z451U Albactye screening cells antibody supplies under fiscal year 2026 option year 2 for contract line items 2001-2020. The contract, which was not set-aside, has an ultimate completion date of September 30, 2028, and is being performed at Fort Johnson South, Louisiana. Alba Bioscience, a Chicago-based subsidiary of Quotient Biodiagnostics, Inc., specializes in producing in vitro...
- This is a firm fixed-price delivery order contract awarded to Alba Bioscience, Inc., a for-profit organization specializing in in vitro diagnostics, blood bank reagents, and medical supplies. The $2,410.00 contract was awarded by the Defense Logistics Agency (DLA) on June 24, 2025 for the provision of ALBACLONE Anti-D Blend products, with a completion date of June 27, 2025. Alba Bioscience is a subsidiary of Quotient Biodiagnostics, Inc. and has expertise in supplying specialized biomedical...
- This federal contract award to Alba Bioscience, Inc., a foreign-owned for-profit organization, is for the delivery of ALBACLONE Anti-A blood typing reagents to the Defense Logistics Agency (DLA) Troop Support Medical. The $3,555.00 firm-fixed-price contract has a period of performance through June 13, 2024 and was awarded on June 10, 2024. Alba Bioscience, a subsidiary of Quotient Biodiagnostics, Inc., is a leading supplier of specialized blood banking products and services to federal...